ClinicalTrials.gov
public full text
Public Domain
Pharmacogenomics for Improving Pediatric ADHD Treatment
This research study is a randomized controlled trial (RCT) to test whether pharmacogenomics (PGx) testing for ADHD medications will help guide clinicians to choose medications and dosages for pediatric ADHD treatment that provide faster symptom relief, fewer or less severe side effects, improve patient quality of life, and lessen emotional stress for parents/guardians of the patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Inflammatory and immune profiling in children and adolescents with attention-deficit/hyperactivity disorder (ADHD): a matched case-control study with longitudinal on/off psychostimulant assessment (ANIME).#159820
- Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders#1372326
- Evaluation of the Effect Foquest® on Sleep in Children Aged 6-12 With ADHD#901299
- Treatment of Children With ADHD Who do Not Fully Respond to Stimulants#837678
- Study of Aripiprazole to Treat Children and Adolescents With Autism#1073860
Record · ID 1196847
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive